comparemela.com

Latest Breaking News On - David pidduck - Page 1 : comparemela.com

MediPharm Labs Reports First Quarter Results

MediPharm Labs Reports First Quarter Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts Strong Financial Position - MediPharm Labs (OTC:MEDIF)

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts Strong Financial Position - MediPharm Labs (OTC:MEDIF)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

MediPharm Labs Reports Fourth Quarter and Full Year Results

MediPharm Labs Reports Fourth Quarter and Full Year Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

MediPharm Labs Inc : MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority

MediPharm Labs Inc : MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canadian CBD-Focused Pharma Co Gets Green Light To Produce Medical Marijuana In Brazil - MediPharm Labs (OTC:MEDIF)

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products for the Brazilian medical cannabis market. MediPharm has already received GMP certifications from the US FDA, the European Union, and Australia's TGA, and holds a drug establishment license from Health Canada. The Brazilian medical cannabis market is projected to reach CAD380m (USD282m) by 2025, according to industry forecasts. MediPharm Labs, which already produces two medical cannabis products with full ANVISA authorization for the Brazilian market, is potentially set for further product authorizations through the regulatory body, according to reports.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.